Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Increasing the daily water intake for the prophylactic treatment of headache: a pilot trial.

Spigt MG, Kuijper EC, Schayck CP, Troost J, Knipschild PG, Linssen VM, Knottnerus JA.

Eur J Neurol. 2005 Sep;12(9):715-8.

PMID:
16128874
2.

A randomized trial on the effects of regular water intake in patients with recurrent headaches.

Spigt M, Weerkamp N, Troost J, van Schayck CP, Knottnerus JA.

Fam Pract. 2012 Aug;29(4):370-5. doi: 10.1093/fampra/cmr112.

3.

Increased water intake to reduce headache: learning from a critical appraisal.

Price A, Burls A.

J Eval Clin Pract. 2015 Dec;21(6):1212-8. doi: 10.1111/jep.12413.

PMID:
26200171
4.
5.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group..

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098
7.

Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.

Cady RK, Voirin J, Farmer K, Browning R, Beach ME, Tarrasch J.

Headache. 2012 May;52(5):749-64. doi: 10.1111/j.1526-4610.2011.02054.x.

PMID:
22188311
8.

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.

Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x.

PMID:
19719543
9.
10.

Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.

Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.

Headache. 2009 May;49(5):732-43. doi: 10.1111/j.1526-4610.2008.01286.x.

PMID:
19178577
11.

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR.

Headache. 2002 Jun;42(6):470-82.

PMID:
12167135
12.

A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.

Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU.

Headache. 2011 Jan;51(1):21-32. doi: 10.1111/j.1526-4610.2010.01796.x.

PMID:
21070228
13.

A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesic™ M) in the treatment of migraine.

Cady RK, Goldstein J, Nett R, Mitchell R, Beach ME, Browning R.

Headache. 2011 Jul-Aug;51(7):1078-86. doi: 10.1111/j.1526-4610.2011.01910.x.

PMID:
21631494
14.

[Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].

Pinsger M, Schimetta W, Volc D, Hiermann E, Riederer F, Pölz W.

Wien Klin Wochenschr. 2006 Jun;118(11-12):327-35. German.

PMID:
16855921
15.

Randomised controlled trial of food elimination diet based on IgG antibodies for the prevention of migraine like headaches.

Mitchell N, Hewitt CE, Jayakody S, Islam M, Adamson J, Watt I, Torgerson DJ.

Nutr J. 2011 Aug 11;10:85. doi: 10.1186/1475-2891-10-85.

16.

The comprehensive headache-related quality of life questionnaire shows significant improvement after withdrawal treatment in medication overuse headache: a pilot study.

Gyüre T, Csépány É, Hajnal B, Kellermann I, Balogh E, Nagy Z, Manhalter N, Bozsik G, Ertsey C.

Ideggyogy Sz. 2014 May 30;67(5-6):169-76; discussion 177.

PMID:
25087376
17.

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group..

Cephalalgia. 2007 Jul;27(7):814-23. Erratum in: Cephalalgia. 2007 Aug;27(8):962.

PMID:
17441971
18.

Validity of an illness severity measure for headache in a population sample of migraine sufferers.

Stewart WF, Lipton RB, Simon D, Liberman J, Von Korff M.

Pain. 1999 Feb;79(2-3):291-301.

PMID:
10068175
19.

A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis.

Breuer B, Pappagallo M, Knotkova H, Guleyupoglu N, Wallenstein S, Portenoy RK.

Clin Ther. 2007 Sep;29(9):2022-30.

PMID:
18035201
20.

Nefazodone for chronic daily headache prophylaxis: an open-label study.

Saper JR, Lake AE, Tepper SJ.

Headache. 2001 May;41(5):465-74.

PMID:
11380644
Items per page

Supplemental Content

Support Center